ConductScience.org, home

Paper · 41468237

Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries.

Danpanichkul P and 16 others. Cancer, 2026. Cited by 17 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries. Papers, record 41468237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41468237

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries.
PubMed
Journal
Cancer
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
10.09, provisional
iCite
Revised in PubMed
2026-01-05
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Danpanichkul PPojsakornhttps://orcid.org/0000-0002-9121-165X
2Pang YYanfang
3Tothanarungroj PPrimrose
4Dejvajara DDisatorn
5Kim DDonghee
6Saokhieo PPreenapun
7Suparan KKanokphong
8Muthiah MDMark D
9Duangsonk KKwanjit
10Bernal DODiego Olavarria

1 to 10 of 17Source PubMed

See all 17 authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastrointestinal NeoplasmsMajor topic
Humans
Female
Male
Incidence
Global Health
Middle Aged
Aged
Adult
Adolescent
Young Adult

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 CA210964NCI NIH HHSUnited StatesP50CA210964PubMedNIH RePORTER
R01 CA256977NIH HHSUnited StatesR01CA256977PubMedNIH RePORTER
K08 CA259534NIH HHSUnited StatesK08CA259534PubMedNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42,963,802Evolution and function of genetic polymorphisms in the Helicobacter pylori type IV secretion pilus protein CagL in gastric carcinogenesis.Cell Commun Signal2026https://conductscience.org/library/papers/42963802PubMed
42,837,495Gastrointestinal symptoms and health-related quality of life before and after pancreatectomy for pancreatic cancer (GO-PANC): longitudinal nationwide study.Br J Surg2026https://conductscience.org/library/papers/42837495PubMed
42,837,076The projected rise of pancreatic cancer mortality in Italy: forecasts until 2035.Updates Surg2026https://conductscience.org/library/papers/42837076PubMed
42,816,832Research advances on CD47 in digestive system cancers: from molecular mechanisms to clinical translation.Mol Med2026https://conductscience.org/library/papers/42816832PubMed
42,812,730Patterns and Frequency of Opioid Use Among Individuals With a History of Gastrointestinal Malignancy: A Cross-Sectional Analysis of the 2019-2020 National Health Interview Survey (NHIS).Cureus2026https://conductscience.org/library/papers/42812730PubMed
42,797,493Barriers and Blueprints: Next-Generation Engineering Strategies for CAR-T Cell Therapy in Gastrointestinal Tumors.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797493PubMed
42,780,747Bispecific antibodies in gastrointestinal cancers: current applications and future perspectives.Front Oncol2026https://conductscience.org/library/papers/42780747PubMed
42,766,638Application of symptom network analysis among patients with gastric cancer: A scoping review.PLoS One2026https://conductscience.org/library/papers/42766638PubMed
42,649,986Biological and Targeted Therapies in the Multidisciplinary Management of Gastrointestinal Cancers.Cancers (Basel)2026https://conductscience.org/library/papers/42649986PubMed
42,649,928Colorectal Cancer Burden and Trends in South-West Oltenia, Romania: A 15-Year Real-World Study from a Regional Referral Cancer Center.Cancers (Basel)2026https://conductscience.org/library/papers/42649928PubMed

1 to 10 of 22

See all 22 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41468237

GET https://conductscience.org/api/papers/v1/41468237/cited_by?page=2